Tesamorelin vs Ipamorelin: Comparative GHRH-R and GHSR-1a Receptor Research

Tesamorelin vs Ipamorelin: Comparative GHRH-R and GHSR-1a Receptor Research In vitro research overview of Ipamorelin selective GHSR-1a (class A GPCR) Gq/calcium mobilisation in cell-based assay systems. For laboratory research use only. Tesamorelin vs Ipamorelin: Comparative GHRH-R and GHSR-1a Receptor Research In Vitro Research Overview Tesamorelin and ipamorelin represent distinct research compounds studied extensively in cell-based assay formats for their selective receptor interactions within growth hormone regulatory pathways. These compounds demonstrate differential receptor selectivity profiles, with tesamorelin exhibiting high affinity for growth hormone-releasing hormone receptor (GHRH-R) systems and ipamorelin showing preferential binding to growth hormone secretagogue receptor 1a (GHSR-1a). Published in vitro research characterizes their molecular interactions, binding affinity profiles, and downstream pathway engagement in defined cell model systems under controlled laboratory conditions. Receptor Pharmacology and Mechanism of Action Tesamorelin GHRH-R Interactions Tesamorelin functions as a synthetic growth hormone-releasing hormone analog demonstrating selective agonist activity at GHRH-R, a class B G-protein coupled receptor. Competitive radioligand binding assays reveal nanomolar binding affinities for GHRH-R expressed in heterologous cell systems. Functional assays utilizing cAMP accumulation endpoints demonstrate robust Gαs/adenylyl cyclase pathway activation following receptor engagement. Cell-based reporter assays show concentration-dependent increases in intracellular cAMP levels, with EC50 values typically ranging in the low nanomolar range across multiple cell model systems. The compound exhibits enhanced proteolytic stability compared to native GHRH peptides, attributed to specific amino acid substitutions that reduce enzymatic degradation while maintaining high receptor binding affinity. Saturation binding experiments using radiolabeled tesamorelin demonstrate reversible, saturable binding kinetics consistent with specific receptor interactions. Ipamorelin GHSR-1a Selectivity Ipamorelin acts via selective GHSR-1a activation, a class A G-protein coupled receptor linked to Gq/11 signaling cascades. Competitive radioligand binding assays demonstrate high selectivity for GHSR-1a over related peptide receptors, including minimal cross-reactivity with ACTH, cortisol, prolactin, and TSH receptor systems. Functional cell-based assays utilizing calcium mobilization endpoints reveal robust intracellular calcium flux responses following receptor activation. The compound demonstrates pentapeptide structure-activity relationships optimized for GHSR-1a selectivity. Displacement binding studies using [125I]-ghrelin show competitive inhibition profiles with Ki values in the nanomolar range. Calcium flux assays in GHSR-1a-expressing cell lines demonstrate concentration-dependent responses with steep Hill coefficients indicative of cooperative binding mechanisms. Comparative Binding Affinity Profiles Receptor Selectivity Analysis Direct comparative binding studies reveal distinct selectivity profiles between tesamorelin and ipamorelin across growth hormone regulatory rece